Acumen Pharmaceuticals, Inc. Depreciation
Acumen Pharmaceuticals, Inc. (ABOS) reported Depreciation of $23.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-12
- Acumen Pharmaceuticals, Inc. depreciation for the quarter ending 2026-06-30 was $11.00K, a 31.25% decline year-over-year.
- Acumen Pharmaceuticals, Inc. depreciation for the quarter ending 2026-03-31 was $12.00K, a 20.00% decline year-over-year.
- Acumen Pharmaceuticals, Inc. depreciation for the quarter ending 2025-12-31 was $12.00K, a 14.29% decline year-over-year.
- Acumen Pharmaceuticals, Inc. depreciation for the quarter ending 2025-09-30 was $15.00K, a 6.25% decline year-over-year.
- Acumen Pharmaceuticals, Inc. depreciation for fiscal 2025 was $58.00K, a 7.94% decline from fiscal 2024.
- Acumen Pharmaceuticals, Inc. depreciation for fiscal 2024 was $63.00K, a 3.28% increase from fiscal 2023.
- Acumen Pharmaceuticals, Inc. depreciation for fiscal 2023 was $61.00K, a 90.63% increase from fiscal 2022.
- Acumen Pharmaceuticals, Inc. depreciation for fiscal 2022 was $32.00K, a 700.00% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $23.00K 10-Q · filed 2026-08-12 | $35.00K derived: sum of 3 quarters · filed 2026-08-12 | $50.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $12.00K 10-Q · filed 2026-05-12 | $24.00K derived: sum of 2 quarters · filed 2026-05-12 | $39.00K derived: sum of 3 quarters · filed 2026-05-12 | $55.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $27.00K derived: sum of 2 quarters · filed 2026-03-26 | $43.00K derived: sum of 3 quarters · filed 2026-08-12 | $58.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $31.00K derived: sum of 2 quarters · filed 2026-08-12 | $46.00K 10-Q · filed 2025-11-12 | $60.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $31.00K 10-Q · filed 2026-08-12 | $45.00K derived: sum of 3 quarters · filed 2026-08-12 | $61.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $15.00K 10-Q · filed 2026-05-12 | $29.00K derived: sum of 2 quarters · filed 2026-05-12 | $45.00K derived: sum of 3 quarters · filed 2026-05-12 | $62.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $30.00K derived: sum of 2 quarters · filed 2026-03-26 | $47.00K derived: sum of 3 quarters · filed 2026-03-26 | $63.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $33.00K derived: sum of 2 quarters · filed 2025-11-12 | $49.00K 10-Q · filed 2025-11-12 | $68.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $33.00K 10-Q · filed 2025-08-12 | $52.00K derived: sum of 3 quarters · filed 2025-08-12 | $65.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $16.00K 10-Q · filed 2025-05-13 | $35.00K derived: sum of 2 quarters · filed 2025-05-13 | $48.00K derived: sum of 3 quarters · filed 2025-05-13 | $63.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $32.00K derived: sum of 2 quarters · filed 2025-03-27 | $47.00K derived: sum of 3 quarters · filed 2025-03-27 | $61.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $28.00K derived: sum of 2 quarters · filed 2024-11-12 | $42.00K 10-Q · filed 2024-11-12 | $54.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $29.00K 10-Q · filed 2024-08-13 | $41.00K derived: sum of 3 quarters · filed 2024-08-13 | $51.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $14.00K 10-Q · filed 2024-05-14 | $26.00K derived: sum of 2 quarters · filed 2024-05-14 | $36.00K derived: sum of 3 quarters · filed 2024-05-14 | $42.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $22.00K derived: sum of 2 quarters · filed 2024-03-26 | $28.00K derived: sum of 3 quarters · filed 2024-03-26 | $32.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $16.00K derived: sum of 2 quarters · filed 2023-11-13 | $20.00K 10-Q · filed 2023-11-13 | $23.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $10.00K 10-Q · filed 2023-08-08 | $13.00K derived: sum of 3 quarters · filed 2023-08-08 | |
| 2022-03-31 | $4.00K 10-Q · filed 2023-05-09 | $7.00K derived: sum of 2 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $4.00K 10-K · filed 2023-03-27 | ||
| 2021-09-30 | $1.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |